Langen KJ - Search Results

1

Whole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-proline.

Börner AR, Langen KJ, Herzog H, Hamacher K, Müller-Mattheis V, Schmitz T, Ackermann R, Coenen HH. Börner AR, et al. Among authors: langen kj. Nucl Med Biol. 2001 Apr;28(3):287-92. doi: 10.1016/s0969-8051(00)00198-0. Nucl Med Biol. 2001. PMID: 11323239

2

Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Herzog H, et al. Among authors: langen kj. Eur J Nucl Med. 1990;16(2):77-83. doi: 10.1007/BF01465913. Eur J Nucl Med. 1990. PMID: 2311622

3

Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.

Schmidt D, Langen KJ, Herzog H, Wirths J, Holschbach M, Kiwit JC, Ziemons K, Coenen HH, Müller-Gärtner H. Schmidt D, et al. Among authors: langen kj. Eur J Nucl Med. 1997 Sep;24(9):1162-6. doi: 10.1007/BF01254250. Eur J Nucl Med. 1997. PMID: 9283111

4

Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors.

Langen KJ, Börner AR, Müller-Mattheis V, Hamacher K, Herzog H, Ackermann R, Coenen HH. Langen KJ, et al. J Nucl Med. 2001 May;42(5):752-4. J Nucl Med. 2001. PMID: 11337571 Free article.

5

Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids.

Langen KJ, Roosen N, Coenen HH, Kuikka JT, Kuwert T, Herzog H, Stöcklin G, Feinendegen LE. Langen KJ, et al. J Nucl Med. 1991 Jun;32(6):1225-9. J Nucl Med. 1991. PMID: 2045937 Free article.

6

SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.

Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, Kuwert T, Stöcklin G, Feinendegen LE. Langen KJ, et al. J Nucl Med. 1990 Mar;31(3):281-6. J Nucl Med. 1990. PMID: 2155314 Free article.

7

Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.

Langen KJ, Mühlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH. Langen KJ, et al. J Nucl Med. 2000 Jul;41(7):1250-5. J Nucl Med. 2000. PMID: 10914918 Free article.

8

3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.

Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner HW. Schmidt D, et al. Among authors: langen kj. Eur J Nucl Med. 2001 Jul;28(7):855-61. doi: 10.1007/s002590100553. Eur J Nucl Med. 2001. PMID: 11504082

9

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O. Weckesser M, et al. Among authors: langen kj. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):422-9. doi: 10.1007/s00259-004-1705-8. Epub 2005 Jan 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15650870 Clinical Trial.

10

Effect of Huntington's and Alzheimer's diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier.

Hankes LV, Coenen HH, Rota E, Langen KJ, Herzog H, Wutz W, Stoecklin G, Feinendegen LE. Hankes LV, et al. Among authors: langen kj. Adv Exp Med Biol. 1991;294:675-8. doi: 10.1007/978-1-4684-5952-4_91. Adv Exp Med Biol. 1991. PMID: 1837697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters